Reprogramming nurse-like cells with interferon γ to interrupt chronic lymphocytic leukemia cell survival

Journal of Biological Chemistry

Volumn 291, Issue 27, 2016, Pages 14356-14362

  Gautam, Shalini ^a   Fatehchand, Kavin ^a   Elavazhagan, Saranya ^a   Reader, Brenda F ^a   Ren, Li ^a,b   Mo, Xiaokui ^a   Byrd, John C ^a   Tridandapani, Susheela ^a   Butchar, Jonathan P ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; ANTIGEN-ANTIBODY REACTIONS; CELLS; DISEASES; NURSING;

ANTIBODY THERAPY; CHRONIC LYMPHOCYTIC LEUKEMIAS; CLL CELLS; CYTOKINE PRODUCTION; EFFECTOR CELLS; INDEPENDENT SIGNALS; INTERFERON-GAMMA;

CYTOLOGY;

CD31 ANTIGEN; CD86 ANTIGEN; FC GAMMA RECEPTOR IA; FC RECEPTOR; GAMMA INTERFERON; HLA DR ANTIGEN; RITUXIMAB; UNCLASSIFIED DRUG; FCGR1A PROTEIN, HUMAN;

ARTICLE; CELL SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ERYTHROCYTE; HUMAN; HUMAN CELL; LEUKEMIA CELL; NUCLEAR REPROGRAMMING; NURSE LIKE CELL; PHAGOCYTOSIS; PRIORITY JOURNAL; UPREGULATION; CELL CULTURE; METABOLISM; PATHOLOGY;

ANTIGENS, CD86; CELL SURVIVAL; CELLS, CULTURED; HLA-DR ANTIGENS; HUMANS; INTERFERON-GAMMA; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; PHAGOCYTOSIS; RECEPTORS, IGG;

EID: 84976624526     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M116.723551     Document Type: Article

References (25)

1. Ysebaert, L., and Fournié, J. J. (2011) Genomic and phenotypic characterization of nurse-like cells that promote drug resistance in chronic lymphocytic leukemia. Leuk. Lymphoma 52, 1404-1406
2. Tsukada, N., Burger, J. A., Zvaifler, N. J., and Kipps, T. J. (2002) Distinctive features of nurselike cells that differentiate in the context of chronic lymphocytic leukemia. Blood 99, 1030-1037
3. Burger, J. A., Tsukada, N., Burger, M., Zvaifler, N. J., Dell'Aquila, M., and Kipps, T. J. (2000) Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cellderived factor-1. Blood 96, 2655-2663
4. Marchesi, F., Cirillo, M., Bianchi, A., Gately, M., Olimpieri, O. M., Cerchiara, E., Renzi, D., Micera, A., Balzamino, B. O., Bonini, S., Onetti Muda, A., and Avvisati, G. (2015) High density of CD68+ /CD163+ tumour-associated macrophages (M2-TAM) at diagnosis is significantly correlated to unfavorable prognostic factors and to poor clinical outcomes in patients with diffuse large B-cell lymphoma. Hematol. Oncol. 33, 110-112
5. Morande, P. E., Zanetti, S. R., Borge, M., Nannini, P., Jancic, C., Bezares, R. F., Bitsmans, A., González, M., Rodríguez, A. L., Galmarini, C. M., Gamberale, R., and Giordano, M. (2012) The cytotoxic activity of Aplidin in chronic lymphocytic leukemia (CLL) is mediated by a direct effect on leukemic cells and an indirect effect on monocyte-derived cells. Invest. New Drugs 30, 1830-1840
6. Schulz, A., Dürr, C., Zenz, T., Döhner, H., Stilgenbauer, S., Lichter, P., and Seiffert, M. (2013) Lenalidomide reduces survival of chronic lymphocytic leukemia cells in primary cocultures by altering the myeloid microenvironment. Blood 121, 2503-2511
7. Perussia, B., Dayton, E. T., Fanning, V., Thiagarajan, P., Hoxie, J., and Trinchieri, G. (1983) Immune interferon and leukocyte-conditioned medium induce normal and leukemic myeloid cells to differentiate along the monocytic pathway. J. Exp. Med. 158, 2058-2080
8. Miller, C. H., Maher, S. G., and Young, H. A. (2009) Clinical use of interferon-γ. Ann. N.Y. Acad. Sci. 1182, 69-79
9. Duluc, D., Corvaisier, M., Blanchard, S., Catala, L., Descamps, P., Gamelin, E., Ponsoda, S., Delneste, Y., Hebbar, M., and Jeannin, P. (2009) Interferon-γ reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages. Int. J. Cancer 125, 367-373
10. Prasse, A., Germann, M., Pechkovsky, D. V., Markert, A., Verres, T., Stahl, M., Melchers, I., Luttmann, W., Müller-Quernheim, J., and Zissel, G. (2007) IL-10-producing monocytes differentiate to alternatively activated macrophages and are increased in atopic patients. J. Allergy Clin. Immunol. 119, 464-471
11. Bergsagel, D. E., von Wussow, P., Alexanian, R., Avvisati, G., Bataille, R., Barlogie, B., Borden, E., Caligaris-Cappio, F., Deicher, H., and Durie, B. G. (1990) Interferons in the treatment of multiple myeloma. J. Clin. Oncol. 8, 1444-1445
12. Kane, A., and Yang, I. (2010) Interferon-γ in brain tumor immunotherapy. Neurosurg. Clin. N. Am. 21, 77-86
13. Gavrilin, M. A., Bouakl, I. J., Knatz, N. L., Duncan, M. D., Hall, M. W., Gunn, J. S., and Wewers, M. D. (2006) Internalization and phagosome escape required for Francisella to induce human monocyte IL-1β processing and release. Proc. Natl. Acad. Sci. U.S.A. 103, 141-146
14. Shah, P., Fatehchand, K., Patel, H., Fang, H., Justiniano, S. E., Mo, X., Jarjoura, D., Tridandapani, S., and Butchar, J. P. (2013) Toll-like receptor 2 ligands regulate monocyte Fcγ receptor expression and function. J. Biol. Chem. 288, 12345-12352
15. Giannoni, P., Pietra, G., Travaini, G., Quarto, R., Shyti, G., Benelli, R., Ottaggio, L., Mingari, M. C., Zupo, S., Cutrona, G., Pierri, I., Balleari, E., Pattarozzi, A., Calvaruso, M., Tripodo, C., et al. (2014) Chronic lymphocytic leukemia nurse-like cells express hepatocyte growth factor receptor (c-MET) and indoleamine 2,3-dioxygenase and display features of immunosuppressive type 2 skewed macrophages. Haematologica 99, 1078-1087
16. Boissard, F., Fournié, J. J., Laurent, C., Poupot, M., and Ysebaert, L. (2015) Nurse like cells: chronic lymphocytic leukemia associated macrophages. Leuk. Lymphoma 56, 1570-1572
17. Mosser, D. M. (2003) The many faces of macrophage activation. J. Leukoc. Biol. 73, 209-212
18. Graziano, R. F., and Fanger, M. W. (1987) Fc γ RI and Fc γ RII on monocytes and granulocytes are cytotoxic trigger molecules for tumor cells. J. Immunol. 139, 3536-3541
19. Guyre, P. M., Morganelli, P. M., and Miller, R. (1983) Recombinant immune interferon increases immunoglobulin G Fc receptors on cultured human mononuclear phagocytes. J. Clin. Invest. 72, 393-397
20. Perussia, B., Dayton, E. T., Lazarus, R., Fanning, V., and Trinchieri, G. (1983) Immune interferon induces the receptor for monomeric IgG1 on human monocytic and myeloid cells. J. Exp. Med. 158, 1092-1113
21. Notter, M., Ludwig, W. D., Bremer, S., and Thiel, E. (1993) Selective targeting of human lymphokine-activated killer cells by CD3 monoclonal antibody against the interferon-inducible high-affinity Fc γ RI receptor (CD64) on autologous acute myeloid leukemic blast cells. Blood 82, 3113-3124
22. Deaglio, S., Vaisitti, T., Bergui, L., Bonello, L., Horenstein, A. L., Tamagnone, L., Boumsell, L., and Malavasi, F. (2005) CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival. Blood 105, 3042-3050
23. Parihar, R., Nadella, P., Lewis, A., Jensen, R., De Hoff, C., Dierksheide, J. E., VanBuskirk, A. M., Magro, C. M., Young, D. C., Shapiro, C. L., and Carson, W. E., 3rd. (2004) A phase I study of interleukin 12 with trastuzumab in patients with human epidermal growth factor receptor-2-overexpressing malignancies: analysis of sustained interferon γ production in a subset of patients. Clin. Cancer Res. 10, 5027-5037
24. Roda, J. M., Parihar, R., and Carson, W. E., 3rd. (2005) CpG-containing oligodeoxynucleotides act through TLR9 to enhance the NK cell cytokine response to antibody-coated tumor cells. J. Immunol. 175, 1619-1627
25. Stephenson, R. M., Lim, C. M., Matthews, M., Dietsch, G., Hershberg, R., and Ferris, R. L. (2013) TLR8 stimulation enhances cetuximab-mediated natural killer cell lysis of head and neck cancer cells and dendritic cell cross-priming of EGFR-specific CD8+ T cells. Cancer Immunol. Immunother. 62, 1347-1357